IMPULSE(SZ:002899) Xin Lang Cai Jing·2025-09-25 02:12Core Viewpoint - The stock of Inpace has shown a slight increase recently, but the overall performance this year has been negative, indicating potential volatility in the company's stock price [1][2]. Group 1: Stock Performance - As of September 25, Inpace's stock price rose by 2.19% to 21.50 CNY per share, with a trading volume of 31.05 million CNY and a turnover rate of 0.99%, resulting in a total market capitalization of 3.178 billion CNY [1]. - Year-to-date, Inpace's stock has decreased by 3.79%, with a 2.48% increase over the last five trading days, a 1.74% decrease over the last 20 days, and an 11.52% decrease over the last 60 days [2]. Group 2: Company Overview - Inpace, established on June 23, 2004, and listed on September 15, 2017, is located in Qingdao, Shandong Province, and specializes in the development, manufacturing, and sales of fitness equipment [2]. - The company's revenue composition includes commercial products (80.92%), other products (12.39%), outdoor products (6.46%), and home products (0.22%) [2]. Group 3: Financial Performance - For the first half of 2025, Inpace reported a revenue of 574 million CNY, reflecting a year-on-year growth of 0.47%, while the net profit attributable to shareholders decreased by 38.09% to 31.67 million CNY [2]. - Since its A-share listing, Inpace has distributed a total of 56.19 million CNY in dividends, with 28.95 million CNY distributed over the last three years [3]. Group 4: Shareholder Information - As of June 30, 2025, Inpace had 19,600 shareholders, an increase of 16.81% from the previous period, with an average of 7,543 circulating shares per shareholder, a decrease of 14.39% [2]. - Among the top ten circulating shareholders, Tianhong Medical Health A holds 1.479 million shares, an increase of 192,000 shares, while Huaxia Stable Growth Mixed Fund is a new entrant with 1.216 million shares [3].